Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03093155
Title Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Yale University
Indications

ovary epithelial cancer

peritoneum cancer

fallopian tube cancer

Therapies

Bevacizumab + Ixabepilone

Ixabepilone

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.